Aravive, Inc. (41) | Uncategorized (19)
Recent Contracts
-
Offer Letter, dated June 2, 2022, by and between Aravive, Inc. and Rudy C. Howard
(Filed With SEC on June 3, 2022)
-
Offer Letter between Leonard Scott Dove, Ph.D. and Aravive, Inc
(Filed With SEC on March 22, 2022)
-
Offer Letter, dated September 8, 2020 between Reshma Rangwala and the Company
(Filed With SEC on March 16, 2021)
-
Description of Capital Securities
(Filed With SEC on March 16, 2021)
-
Amendment to Offer Letter dated as of January 25, 2021 by and between Aravive, Inc. and Gail McIntyre, Ph.D
(Filed With SEC on January 27, 2021)
-
Option Agreement dated April 8, 2020 by and between the Company and Srini Akkaraju
(Filed With SEC on April 9, 2020)
-
Amendment to Offer Letter dated as of April 8, 2020 by and between the Company and Gail McIntyre
(Filed With SEC on April 9, 2020)
-
Option Agreement dated April 8, 2020 by and between the Company and Robert Hoffman
(Filed With SEC on April 9, 2020)
-
Option Agreement dated April 8, 2020 by and between the Company and Jay Shepard
(Filed With SEC on April 9, 2020)
-
Separation Agreement dated April 8, 2020 between the Company and Rekha Hemrajani
(Filed With SEC on April 9, 2020)
-
Investment Agreement, dated as of April 6, 2020, by and among the Company, Eshelman Ventures, LLC, and, solely for purposes of Article IV and Article V of the Investment...
(Filed With SEC on April 9, 2020)
-
Offer Letter, dated March 26, 2020 between Gail McIntyre and Aravive, Inc
(Filed With SEC on March 27, 2020)
-
Offer Letter, dated March 26, 2020, between Vinay Shah and Aravive, Inc
(Filed With SEC on March 27, 2020)
-
Description of Capital Securities
(Filed With SEC on March 27, 2020)
-
Offer Letter, dated January 8, 2020, between Rekha Hemrajani and Aravive, Inc
(Filed With SEC on January 9, 2020)
-
Amendment to Jay Shepard Offer Letter dated as of February 28, 2019
(Filed With SEC on March 6, 2019)
-
Offer Letter dated February 1, 2017 and the amendment thereto dated May 30, 2018 by and between Aravive Biologics, Inc. and Vinay Shah
(Filed With SEC on February 12, 2019)
-
Offer Letter dated January 1, 2017 by and between Aravive Biologics, Inc. and Gail McIntyre
(Filed With SEC on February 12, 2019)
-
Amendment to Jay Shepard Offer Letter dated as of February 6, 2019
(Filed With SEC on February 12, 2019)